Pages that link to "Q37976851"
Jump to navigation
Jump to search
The following pages link to Systematic review of the cost-effectiveness of varenicline vs. bupropion for smoking cessation (Q37976851):
Displaying 11 items.
- Effectiveness of dentist's intervention in smoking cessation: A review (Q26768297) (← links)
- New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline? (Q28277165) (← links)
- Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice (Q33582051) (← links)
- Model-based economic evaluations in smoking cessation and their transferability to new contexts: a systematic review (Q33697800) (← links)
- Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence (Q34366802) (← links)
- Tobacco use and cessation for cancer survivors: an overview for clinicians (Q35226577) (← links)
- Cost-effectiveness of retreatment with varenicline after failure with or relapse after initial treatment for smoking cessation (Q36486726) (← links)
- The efficacy of varenicline in achieving abstinence among waterpipe tobacco smokers - study protocol for a randomized controlled trial (Q37579044) (← links)
- Cost-effectiveness of increasing the reach of smoking cessation interventions in Germany: results from the EQUIPTMOD. (Q47574550) (← links)
- An examination of user costs in relation to smokers using a cessation service based in the UK. (Q55003151) (← links)
- A cost-benefit analysis of smoking cessation prescription coverage from a US payer perspective (Q90429386) (← links)